The research on the change of chemosensitivity of gefitinib-resistant lung adenocarcinoma cell caused by EGFR-T790M mutation

Background and purpose: Chemotherapy is an alternative treatment option, which could still get a therapeutic effect, when the EGFR-TKI treatment of non-small cell lung cancer failed. Studies have shown that RR, TYMS, ERCC1 and TUBB3 have respectively relationship with chemosensitivity of gemcitabine...

全面介紹

書目詳細資料

Principais autores:	李学真, 邹文, 马进安
格式:	Artigo
語言:	Inglês
出版:	Editorial Office of China Oncology 2015-05-01
叢編:	Zhongguo aizheng zazhi
主題:	Adenocarcinoma EGFR-T790M mutation Gefitinib-resistant ERCC1 TUBB3 TS RRM1 Chemotherapy
在線閱讀:	http://www.china-oncology.com/thesisDetails#10.3969/j.issn.1007-3969.2015.02.008
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!